APO Research
Talk to an analyst

APO RESEARCH · REPORT

Advance Directives Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Advance Directives Software Market Outlook and Growth Opportunities 2026

4 July 2026200 pages

Choose your research edition.

Industry ResearchAdvance Directives Software Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Advance Directives Software Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Advance Directives Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advance Directives Software Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Advance Directives Software Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global Advance Directives Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Advance Directives Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Advance Directives Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Advance Directives Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Advance Directives Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Advance Directives Software market include Island Health, Honor My Decisions, WiserCare Inc., ADvault, Inc., VyncaCare, Iris Healthcare, Bronson Health Care Group, Inc., Koda Health and New Century Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Advance Directives Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Advance Directives Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Advance Directives Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Advance Directives Software market.

Advance Directives Software Segment by Company

Island Health

Honor My Decisions

WiserCare Inc.

ADvault, Inc.

VyncaCare

Iris Healthcare

Bronson Health Care Group, Inc.

Koda Health

New Century Health

Thanacare

ThroughCare, Inc.

Vital Decisions

Affirm Health Inc.

MIDEO

Sharp HealthCare

ACP Decisions

Advance Directives Software Segment by Type

Document Preparation Software

Electronic Health Record (EHR) Integration

Online Platforms and Portals

Comprehensive Healthcare Planning Software

Advance Directives Software Segment by Application

Healthcare

Other

Advance Directives Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Advance Directives Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Advance Directives Software key companies, revenue, market share, and recent developments.

3. To split the Advance Directives Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Advance Directives Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Advance Directives Software significant trends, drivers, influence factors in global and regions.

6. To analyze Advance Directives Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advance Directives Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advance Directives Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advance Directives Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Advance Directives Software industry.

Chapter 3: Detailed analysis of Advance Directives Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Advance Directives Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Advance Directives Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Advance Directives Software Industry Trends Table 2. Advance Directives Software Industry Drivers Table 3. Advance Directives Software Industry Opportunities and Challenges Table 4. Advance Directives Software Industry Restraints Table 5. Global Advance Directives Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Advance Directives Software Revenue Share by Company (2021-2026) Table 7. Global Advance Directives Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Advance Directives Software Key Company Manufacturing Base & Headquarters Table 9. Global Advance Directives Software Company, Product Type & Application Table 10. Global Advance Directives Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Advance Directives Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Document Preparation Software Table 15. Significant Companies of Electronic Health Record (EHR) Integration Table 16. Significant Companies of Online Platforms and Portals Table 17. Significant Companies of Comprehensive Healthcare Planning Software Table 18. Global Advance Directives Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Advance Directives Software Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Advance Directives Software Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Advance Directives Software Sales Value Share by Type (2021-2026) Table 22. Global Advance Directives Software Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Healthcare Table 24. Significant Companies of Other Table 25. Global Advance Directives Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Advance Directives Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Advance Directives Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Advance Directives Software Sales Value Share by Application (2021-2026) Table 29. Global Advance Directives Software Sales Value Share by Application (2027-2032) Table 30. Global Advance Directives Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Advance Directives Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Advance Directives Software Sales Value Share by Region (2021-2026) Table 33. Global Advance Directives Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Advance Directives Software Sales Value Share by Region (2027-2032) Table 35. Global Advance Directives Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Advance Directives Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Advance Directives Software Sales Value Market Share by Country (2021-2026) Table 38. Global Advance Directives Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Advance Directives Software Sales Value Market Share by Country (2027-2032) Table 40. Island Health Company Information Table 41. Island Health Business Overview Table 42. Island Health Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Island Health Advance Directives Software Product Portfolio Table 44. Island Health Recent Development Table 45. Honor My Decisions Company Information Table 46. Honor My Decisions Business Overview Table 47. Honor My Decisions Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Honor My Decisions Advance Directives Software Product Portfolio Table 49. Honor My Decisions Recent Development Table 50. WiserCare Inc. Company Information Table 51. WiserCare Inc. Business Overview Table 52. WiserCare Inc. Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. WiserCare Inc. Advance Directives Software Product Portfolio Table 54. WiserCare Inc. Recent Development Table 55. ADvault, Inc. Company Information Table 56. ADvault, Inc. Business Overview Table 57. ADvault, Inc. Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. ADvault, Inc. Advance Directives Software Product Portfolio Table 59. ADvault, Inc. Recent Development Table 60. VyncaCare Company Information Table 61. VyncaCare Business Overview Table 62. VyncaCare Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. VyncaCare Advance Directives Software Product Portfolio Table 64. VyncaCare Recent Development Table 65. Iris Healthcare Company Information Table 66. Iris Healthcare Business Overview Table 67. Iris Healthcare Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Iris Healthcare Advance Directives Software Product Portfolio Table 69. Iris Healthcare Recent Development Table 70. Bronson Health Care Group, Inc. Company Information Table 71. Bronson Health Care Group, Inc. Business Overview Table 72. Bronson Health Care Group, Inc. Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Bronson Health Care Group, Inc. Advance Directives Software Product Portfolio Table 74. Bronson Health Care Group, Inc. Recent Development Table 75. Koda Health Company Information Table 76. Koda Health Business Overview Table 77. Koda Health Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Koda Health Advance Directives Software Product Portfolio Table 79. Koda Health Recent Development Table 80. New Century Health Company Information Table 81. New Century Health Business Overview Table 82. New Century Health Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. New Century Health Advance Directives Software Product Portfolio Table 84. New Century Health Recent Development Table 85. Thanacare Company Information Table 86. Thanacare Business Overview Table 87. Thanacare Advance Directives Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Thanacare Advance Directives Software Product Portfolio Table 89. Thanacare Recent Development Table 90. ThroughCare, Inc. Company Information Table 91. ThroughCare, Inc. Business Overview Table 92. ThroughCare, Inc. Advance Directives Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. ThroughCare, Inc. Advance Directives Software Product Portfolio Table 94. ThroughCare, Inc. Recent Development Table 95. Vital Decisions Company Information Table 96. Vital Decisions Business Overview Table 97. Vital Decisions Advance Directives Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Vital Decisions Advance Directives Software Product Portfolio Table 99. Vital Decisions Recent Development Table 100. Affirm Health Inc. Company Information Table 101. Affirm Health Inc. Business Overview Table 102. Affirm Health Inc. Advance Directives Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Affirm Health Inc. Advance Directives Software Product Portfolio Table 104. Affirm Health Inc. Recent Development Table 105. MIDEO Company Information Table 106. MIDEO Business Overview Table 107. MIDEO Advance Directives Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. MIDEO Advance Directives Software Product Portfolio Table 109. MIDEO Recent Development Table 110. Sharp HealthCare Company Information Table 111. Sharp HealthCare Business Overview Table 112. Sharp HealthCare Advance Directives Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Sharp HealthCare Advance Directives Software Product Portfolio Table 114. Sharp HealthCare Recent Development Table 115. ACP Decisions Company Information Table 116. ACP Decisions Business Overview Table 117. ACP Decisions Advance Directives Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. ACP Decisions Advance Directives Software Product Portfolio Table 119. ACP Decisions Recent Development Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Advance Directives Software Product Image Figure 2. Global Advance Directives Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advance Directives Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Advance Directives Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Document Preparation Software Image Figure 8. Electronic Health Record (EHR) Integration Image Figure 9. Online Platforms and Portals Image Figure 10. Comprehensive Healthcare Planning Software Image Figure 11. Global Advance Directives Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Advance Directives Software Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Advance Directives Software Sales Value Share by Type (2021-2032) Figure 14. Healthcare Image Figure 15. Other Image Figure 16. Global Advance Directives Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Advance Directives Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Advance Directives Software Sales Value Share by Application (2021-2032) Figure 19. Global Advance Directives Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Advance Directives Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Advance Directives Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Advance Directives Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Advance Directives Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Advance Directives Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Advance Directives Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Advance Directives Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Advance Directives Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Advance Directives Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Advance Directives Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Advance Directives Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Advance Directives Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Advance Directives Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Advance Directives Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Document Preparation Software
  • Electronic Health Record (EHR) Integration
  • Online Platforms and Portals
  • Comprehensive Healthcare Planning Software
Applications
  • Healthcare
  • Other
Companies covered
  • Island Health
  • Honor My Decisions
  • WiserCare Inc.
  • ADvault, Inc.
  • VyncaCare
  • Iris Healthcare
  • Bronson Health Care Group, Inc.
  • Koda Health
  • New Century Health
  • Thanacare
  • ThroughCare, Inc.
  • Vital Decisions
  • Affirm Health Inc.
  • MIDEO
  • Sharp HealthCare
  • ACP Decisions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Advance Directives Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Advance Directives Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Advance Directives Software Market Dynamics
  1. 2.1 Advance Directives Software Industry Trends
  2. 2.2 Advance Directives Software Industry Drivers
  3. 2.3 Advance Directives Software Industry Opportunities and Challenges
  4. 2.4 Advance Directives Software Industry Restraints
3 Advance Directives Software Market by Company
  1. 3.1 Global Advance Directives Software Company Revenue Ranking in 2025
  2. 3.2 Global Advance Directives Software Revenue by Company (2021-2026)
  3. 3.3 Global Advance Directives Software Company Ranking (2024-2026)
  4. 3.4 Global Advance Directives Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Advance Directives Software Company Product Type and Application
  6. 3.6 Global Advance Directives Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Advance Directives Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Advance Directives Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Advance Directives Software Market by Type
  1. 4.1 Advance Directives Software Type Introduction
  2. 4.1.1 Document Preparation Software
  3. 4.1.2 Electronic Health Record (EHR) Integration
  4. 4.1.3 Online Platforms and Portals
  5. 4.1.4 Comprehensive Healthcare Planning Software
  6. 4.2 Global Advance Directives Software Sales Value by Type
  7. 4.2.1 Global Advance Directives Software Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Advance Directives Software Sales Value by Type (2021-2032)
  9. 4.2.3 Global Advance Directives Software Sales Value Share by Type (2021-2032)
5 Advance Directives Software Market by Application
  1. 5.1 Advance Directives Software Application Introduction
  2. 5.1.1 Healthcare
  3. 5.1.2 Other
  4. 5.2 Global Advance Directives Software Sales Value by Application
  5. 5.2.1 Global Advance Directives Software Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Advance Directives Software Sales Value by Application (2021-2032)
  7. 5.2.3 Global Advance Directives Software Sales Value Share by Application (2021-2032)
6 Advance Directives Software Regional Value Analysis
  1. 6.1 Global Advance Directives Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Advance Directives Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Advance Directives Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Advance Directives Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Advance Directives Software Sales Value (2021-2032)
  7. 6.3.2 North America Advance Directives Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Advance Directives Software Sales Value (2021-2032)
  10. 6.4.2 Europe Advance Directives Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Advance Directives Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Advance Directives Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Advance Directives Software Sales Value (2021-2032)
  16. 6.6.2 South America Advance Directives Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Advance Directives Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Advance Directives Software Sales Value Share by Country, 2025 VS 2032
7 Advance Directives Software Country-level Value Analysis
  1. 7.1 Global Advance Directives Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Advance Directives Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Advance Directives Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Advance Directives Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Advance Directives Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Advance Directives Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Advance Directives Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Advance Directives Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Advance Directives Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Advance Directives Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Advance Directives Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Advance Directives Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Advance Directives Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Advance Directives Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Advance Directives Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Advance Directives Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Advance Directives Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Advance Directives Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Advance Directives Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Advance Directives Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Advance Directives Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Advance Directives Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Advance Directives Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Advance Directives Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Advance Directives Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Advance Directives Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Advance Directives Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Advance Directives Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Advance Directives Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Advance Directives Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Advance Directives Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Advance Directives Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Advance Directives Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Advance Directives Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Advance Directives Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Island Health
  2. 8.1.1 Island Health Company Information
  3. 8.1.2 Island Health Business Overview
  4. 8.1.3 Island Health Advance Directives Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Island Health Advance Directives Software Product Portfolio
  6. 8.1.5 Island Health Recent Developments
  7. 8.2 Honor My Decisions
  8. 8.2.1 Honor My Decisions Company Information
  9. 8.2.2 Honor My Decisions Business Overview
  10. 8.2.3 Honor My Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Honor My Decisions Advance Directives Software Product Portfolio
  12. 8.2.5 Honor My Decisions Recent Developments
  13. 8.3 WiserCare Inc.
  14. 8.3.1 WiserCare Inc. Company Information
  15. 8.3.2 WiserCare Inc. Business Overview
  16. 8.3.3 WiserCare Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 WiserCare Inc. Advance Directives Software Product Portfolio
  18. 8.3.5 WiserCare Inc. Recent Developments
  19. 8.4 ADvault, Inc.
  20. 8.4.1 ADvault, Inc. Company Information
  21. 8.4.2 ADvault, Inc. Business Overview
  22. 8.4.3 ADvault, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ADvault, Inc. Advance Directives Software Product Portfolio
  24. 8.4.5 ADvault, Inc. Recent Developments
  25. 8.5 VyncaCare
  26. 8.5.1 VyncaCare Company Information
  27. 8.5.2 VyncaCare Business Overview
  28. 8.5.3 VyncaCare Advance Directives Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 VyncaCare Advance Directives Software Product Portfolio
  30. 8.5.5 VyncaCare Recent Developments
  31. 8.6 Iris Healthcare
  32. 8.6.1 Iris Healthcare Company Information
  33. 8.6.2 Iris Healthcare Business Overview
  34. 8.6.3 Iris Healthcare Advance Directives Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Iris Healthcare Advance Directives Software Product Portfolio
  36. 8.6.5 Iris Healthcare Recent Developments
  37. 8.7 Bronson Health Care Group, Inc.
  38. 8.7.1 Bronson Health Care Group, Inc. Company Information
  39. 8.7.2 Bronson Health Care Group, Inc. Business Overview
  40. 8.7.3 Bronson Health Care Group, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bronson Health Care Group, Inc. Advance Directives Software Product Portfolio
  42. 8.7.5 Bronson Health Care Group, Inc. Recent Developments
  43. 8.8 Koda Health
  44. 8.8.1 Koda Health Company Information
  45. 8.8.2 Koda Health Business Overview
  46. 8.8.3 Koda Health Advance Directives Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Koda Health Advance Directives Software Product Portfolio
  48. 8.8.5 Koda Health Recent Developments
  49. 8.9 New Century Health
  50. 8.9.1 New Century Health Company Information
  51. 8.9.2 New Century Health Business Overview
  52. 8.9.3 New Century Health Advance Directives Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 New Century Health Advance Directives Software Product Portfolio
  54. 8.9.5 New Century Health Recent Developments
  55. 8.10 Thanacare
  56. 8.10.1 Thanacare Company Information
  57. 8.10.2 Thanacare Business Overview
  58. 8.10.3 Thanacare Advance Directives Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Thanacare Advance Directives Software Product Portfolio
  60. 8.10.5 Thanacare Recent Developments
  61. 8.11 ThroughCare, Inc.
  62. 8.11.1 ThroughCare, Inc. Company Information
  63. 8.11.2 ThroughCare, Inc. Business Overview
  64. 8.11.3 ThroughCare, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ThroughCare, Inc. Advance Directives Software Product Portfolio
  66. 8.11.5 ThroughCare, Inc. Recent Developments
  67. 8.12 Vital Decisions
  68. 8.12.1 Vital Decisions Company Information
  69. 8.12.2 Vital Decisions Business Overview
  70. 8.12.3 Vital Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vital Decisions Advance Directives Software Product Portfolio
  72. 8.12.5 Vital Decisions Recent Developments
  73. 8.13 Affirm Health Inc.
  74. 8.13.1 Affirm Health Inc. Company Information
  75. 8.13.2 Affirm Health Inc. Business Overview
  76. 8.13.3 Affirm Health Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Affirm Health Inc. Advance Directives Software Product Portfolio
  78. 8.13.5 Affirm Health Inc. Recent Developments
  79. 8.14 MIDEO
  80. 8.14.1 MIDEO Company Information
  81. 8.14.2 MIDEO Business Overview
  82. 8.14.3 MIDEO Advance Directives Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MIDEO Advance Directives Software Product Portfolio
  84. 8.14.5 MIDEO Recent Developments
  85. 8.15 Sharp HealthCare
  86. 8.15.1 Sharp HealthCare Company Information
  87. 8.15.2 Sharp HealthCare Business Overview
  88. 8.15.3 Sharp HealthCare Advance Directives Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sharp HealthCare Advance Directives Software Product Portfolio
  90. 8.15.5 Sharp HealthCare Recent Developments
  91. 8.16 ACP Decisions
  92. 8.16.1 ACP Decisions Company Information
  93. 8.16.2 ACP Decisions Business Overview
  94. 8.16.3 ACP Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ACP Decisions Advance Directives Software Product Portfolio
  96. 8.16.5 ACP Decisions Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst